<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Pharm Exec Podcast Interviews via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pharm Exec Podcast Interviews' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Pharm+Exec+Podcast+Interviews&t=Pharm+Exec+Podcast+Interviews&s=Search&f=source]]></link>
        <lastBuildDate>Fri, 18 Feb 2011 20:16:27 +0100</lastBuildDate>
        <item>
            <title>EMERGING LEADERS:  Claire Thomas</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-10.mp3</link>
            <description>Claire Thomas, SVP Human Resources, GlaxoSmithKline (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273885</comments>
            <pubDate>Mon, 20 Dec 2010 21:28:28 +0100</pubDate>
            <guid isPermaLink="false">4273885</guid>        </item>
        <item>
            <title>Trends in Assessing Costs - Part 3</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/cleartrial-rs-03.mp3</link>
            <description>(Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273895</comments>
            <pubDate>Mon, 15 Nov 2010 21:09:18 +0100</pubDate>
            <guid isPermaLink="false">4273895</guid>        </item>
        <item>
            <title>Trends in Assessing Costs - Part 2</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/cleartrial-rs-02.mp3</link>
            <description>(Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273896</comments>
            <pubDate>Mon, 08 Nov 2010 21:08:06 +0100</pubDate>
            <guid isPermaLink="false">4273896</guid>        </item>
        <item>
            <title>Trends in Assessing Costs - Part 1</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/cleartrial-rs-01.mp3</link>
            <description>(Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273897</comments>
            <pubDate>Thu, 04 Nov 2010 19:34:42 +0100</pubDate>
            <guid isPermaLink="false">4273897</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  Lynn Taylor</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-09.mp3</link>
            <description>Lynn Taylor,VP Government Affairs, EMD Serono Company (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273886</comments>
            <pubDate>Fri, 15 Oct 2010 21:26:18 +0100</pubDate>
            <guid isPermaLink="false">4273886</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  Charlotte Sibley</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-08.mp3</link>
            <description>Charlotte Sibley, SVP Business Management, Shire Pharmaceuticals (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273887</comments>
            <pubDate>Fri, 15 Oct 2010 21:24:12 +0100</pubDate>
            <guid isPermaLink="false">4273887</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  Amit Munshi</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-07.mp3</link>
            <description>Amit Munshi, Chief Business Officer and Co founder, Kythera Pharmaceuticals (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273888</comments>
            <pubDate>Fri, 15 Oct 2010 21:22:24 +0100</pubDate>
            <guid isPermaLink="false">4273888</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  Elona Kogan</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-06.mp3</link>
            <description>Elona Kogan, Associate General Counsel, King Pharmaceuticals (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273889</comments>
            <pubDate>Fri, 15 Oct 2010 21:21:00 +0100</pubDate>
            <guid isPermaLink="false">4273889</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  Dr. Jason Hwang</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-05.mp3</link>
            <description>Dr. Jason Hwang, Executive Director of Health Care Innosight Institute (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273890</comments>
            <pubDate>Fri, 15 Oct 2010 21:19:13 +0100</pubDate>
            <guid isPermaLink="false">4273890</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  John Holloway</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-04.mp3</link>
            <description>John Holloway, VP Business Development, Achaogen Biopharmaceuticals (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273891</comments>
            <pubDate>Fri, 15 Oct 2010 21:17:47 +0100</pubDate>
            <guid isPermaLink="false">4273891</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  Indranil Bagchi</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-03.mp3</link>
            <description>Indranil Bagchi, VP Market Access Specialty Care Business Unit Pfizer (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273892</comments>
            <pubDate>Fri, 15 Oct 2010 21:15:59 +0100</pubDate>
            <guid isPermaLink="false">4273892</guid>        </item>
        <item>
            <title>EMERGING LEADERS:  Bill Anderson</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-02.mp3</link>
            <description>Bill Anderson, SVP BioOncology Business Unit, Genentech (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273893</comments>
            <pubDate>Fri, 15 Oct 2010 21:13:56 +0100</pubDate>
            <guid isPermaLink="false">4273893</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Marylyn Nyman</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/epl-rs-01.mp3</link>
            <description>Marylyn Nyman, CEO, The Nyman Group (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273894</comments>
            <pubDate>Fri, 15 Oct 2010 21:10:34 +0100</pubDate>
            <guid isPermaLink="false">4273894</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Elizabeth Mutisya</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-mutisya.mp3</link>
            <description>Elizabeth Mutisya, VP, US Medical Affairs, CMO, Solvay Pharmaceuticals (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983485</comments>
            <pubDate>Wed, 11 Nov 2009 19:14:03 +0100</pubDate>
            <guid isPermaLink="false">2983485</guid>        </item>
        <item>
            <title>Bill Trombetta 2009 Industry Audit (Part 5)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit09-rs-05.mp3</link>
            <description>n this final episode, Trombetta reviews the business strategy of the survey runner up, Genentech and how the integration with Roche may impact the success of this perennial favorite in the survey. We end with a fairly optimistic view that big pharma is far from down on the count its cash hoard and considerable human assets will continue to help it move forward agains the competitive threat of smaller, nimble and more focused stealth pharmas. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983498</comments>
            <pubDate>Thu, 05 Nov 2009 18:11:19 +0100</pubDate>
            <guid isPermaLink="false">2983498</guid>        </item>
        <item>
            <title>Bill Trombetta 2009 Industry Audit (Part 4)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit09-rs-04.mp3</link>
            <description>Professor Trombetta tackles the question of whether size and scale matter as a predictor of shareholder value his answer is management drives results, regardless of the company being big or small. He also profiles the attributes that made Gilead Sciences the winner of this year’s poll, and how Biogen/Idec slipped from first to third place. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983499</comments>
            <pubDate>Wed, 04 Nov 2009 18:09:21 +0100</pubDate>
            <guid isPermaLink="false">2983499</guid>        </item>
        <item>
            <title>Bill Trombetta 2009 Industry Audit (Part 3)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit09-rs-03.mp3</link>
            <description>Good management is a mainstay for success regardless of whether a company is big or small. In this episode, Trombetta describes his metrics-driven approach to evaluating internal management strategies and highlights best practices from individual companies. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983500</comments>
            <pubDate>Tue, 03 Nov 2009 18:07:42 +0100</pubDate>
            <guid isPermaLink="false">2983500</guid>        </item>
        <item>
            <title>Bill Trombetta 2009 Industry Audit (Part 2)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit09-rs-02.mp3</link>
            <description>Professor Trombetta gives a frank assessment of factors that are transforming the commercial and policy environment in the biopharm sector. Will the industry remain resilient in the wake of the worst global recession of the post-war era? (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983501</comments>
            <pubDate>Mon, 02 Nov 2009 18:06:09 +0100</pubDate>
            <guid isPermaLink="false">2983501</guid>        </item>
        <item>
            <title>Bill Trombetta 2009 Industry Audit (Part 1)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit09-rs-01.mp3</link>
            <description>Bill Trombetta explains changes in key evaluation metrics for this year’s survey as well as the implications of adding 11 new companies to the list, making it reflective of the emergence of generics, biotech and specialty firms as key competitors to traditional big pharma. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983502</comments>
            <pubDate>Sun, 01 Nov 2009 15:03:18 +0100</pubDate>
            <guid isPermaLink="false">2983502</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Kathryn Metcalfe</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-metcalfe.mp3</link>
            <description>Kathryn Metcalfe, VP, Corporate Reputation and Policy Communications, Pfizer (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983486</comments>
            <pubDate>Sat, 24 Oct 2009 19:10:22 +0100</pubDate>
            <guid isPermaLink="false">2983486</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Michelle Dipp</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-dipp.mp3</link>
            <description>Michelle Dipp, VP &amp; Head of US Center of Excellence for External Drug Discovery, GlaxoSmithKline (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983487</comments>
            <pubDate>Fri, 23 Oct 2009 19:08:18 +0100</pubDate>
            <guid isPermaLink="false">2983487</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Paulash Mohsen</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-mohsen.mp3</link>
            <description>Paulash Mohsen, Vice President, Primary Care Strategy, Pfizer (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983488</comments>
            <pubDate>Thu, 22 Oct 2009 19:06:03 +0100</pubDate>
            <guid isPermaLink="false">2983488</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Jennifer Smith</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-smith.mp3</link>
            <description>Jennifer Smith, Executive Director, Medical Education, Wyeth (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983489</comments>
            <pubDate>Wed, 21 Oct 2009 19:03:29 +0100</pubDate>
            <guid isPermaLink="false">2983489</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Joe Sheilds</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-scheilds.mp3</link>
            <description>Joe Shields, Product Director, Enbrel (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983490</comments>
            <pubDate>Tue, 20 Oct 2009 18:55:16 +0100</pubDate>
            <guid isPermaLink="false">2983490</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Scott Cormack</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-cormack.mp3</link>
            <description>Scott Cormack, President and CEO, OncoGenex Pharmaceuticals (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983491</comments>
            <pubDate>Mon, 19 Oct 2009 18:53:15 +0100</pubDate>
            <guid isPermaLink="false">2983491</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Frank Karbe</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-karbe.mp3</link>
            <description>Frank Karbe, Chief Financial Officer, Exelixis (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983492</comments>
            <pubDate>Sun, 18 Oct 2009 18:51:17 +0100</pubDate>
            <guid isPermaLink="false">2983492</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Virginia Carnahan</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-carnahan.mp3</link>
            <description>Virginia Carnahan, Vice President, New Product Planning and Strategy, Vertex Pharmaceuticals (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983493</comments>
            <pubDate>Sat, 17 Oct 2009 18:48:01 +0100</pubDate>
            <guid isPermaLink="false">2983493</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Luca Santarelli</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-santarelli.mp3</link>
            <description>Luca Santarelli, Global Head of Clinical Research and Exploratory Development in CNS, Roche (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983494</comments>
            <pubDate>Fri, 16 Oct 2009 18:37:06 +0100</pubDate>
            <guid isPermaLink="false">2983494</guid>        </item>
        <item>
            <title>TFC:  Trends in Patient Access</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/tfc-rs-06.mp3</link>
            <description>Pharmaceutical Executive Editor-in-Chief Bill Looney visits with Bob Mauch, president of Xcenda, to discuss: How health reform might affect quality of care and what preparations are being made by stakeholders like manufacturers and payers. Immediate and potential long-term impact of biosimilars in the specialty space. Use of patient adherence and patient assistance programs as a way to promote proper therapy utilization. The current and future state of hot button issues like comparative effectiveness and REMS. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983496</comments>
            <pubDate>Fri, 16 Oct 2009 18:24:26 +0100</pubDate>
            <guid isPermaLink="false">2983496</guid>        </item>
        <item>
            <title>EMERGING LEADERS: Carrolee Barlow</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/el-rs-barlow.mp3</link>
            <description>Carrolee Barlow, Chief Scientific Officer, BrainCells (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983495</comments>
            <pubDate>Thu, 15 Oct 2009 18:31:46 +0100</pubDate>
            <guid isPermaLink="false">2983495</guid>        </item>
        <item>
            <title>TFC:  The Future of Oncology</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/tfc-rs-05.mp3</link>
            <description>With the U.S. healthcare system at an unprecedented crossroads, cancer care has emerged as one of the most hotly debated subjects. Stakeholders include manufacturers, physicians, patients, payers and service providers even the government itself. And all have their own set of concerns to be addressed. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983497</comments>
            <pubDate>Mon, 24 Aug 2009 18:13:54 +0100</pubDate>
            <guid isPermaLink="false">2983497</guid>        </item>
        <item>
            <title>WOTY:  Deborah Dunsire of Millennium Pharmaceuticals</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-13.mp3</link>
            <description>Deborah Dunsire of Millennium Pharmaceuticals shares the path she took to an incredible career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690192</comments>
            <pubDate>Tue, 11 Aug 2009 15:22:25 +0100</pubDate>
            <guid isPermaLink="false">2690192</guid>        </item>
        <item>
            <title>WOTY:  Lynn Gaudioso of Ivanhoe Strategies</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-08.mp3</link>
            <description>Lynn Gaudioso of Ivanhoe Strategies talks about her career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690197</comments>
            <pubDate>Sat, 11 Apr 2009 15:09:24 +0100</pubDate>
            <guid isPermaLink="false">2690197</guid>        </item>
        <item>
            <title>WOTY:  Kathy Giusti of MMRF and MMRC</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-12.mp3</link>
            <description>Kathy Giusti of MMRF and MMRC discusses her career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690193</comments>
            <pubDate>Wed, 01 Apr 2009 15:17:51 +0100</pubDate>
            <guid isPermaLink="false">2690193</guid>        </item>
        <item>
            <title>WOTY:  Tamar Howsen of JSB Partners</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-11.mp3</link>
            <description>Tamar Howsen of JSB Partners talks about her career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690194</comments>
            <pubDate>Wed, 01 Apr 2009 15:16:03 +0100</pubDate>
            <guid isPermaLink="false">2690194</guid>        </item>
        <item>
            <title>WOTY:  Catherine Sibley of Shire</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-10.mp3</link>
            <description>Maureen Regan of Regan Campbell Ward McCann reflects on her career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690195</comments>
            <pubDate>Wed, 01 Apr 2009 15:13:35 +0100</pubDate>
            <guid isPermaLink="false">2690195</guid>        </item>
        <item>
            <title>WOTY:  Maureen Regan of Regan Campbell Ward McCann</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-09.mp3</link>
            <description>Maureen Regan of Regan Campbell Ward McCann reflects on her career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690196</comments>
            <pubDate>Wed, 01 Apr 2009 15:11:15 +0100</pubDate>
            <guid isPermaLink="false">2690196</guid>        </item>
        <item>
            <title>WOTY:  Sarah Harrison of H&amp;S Enterprise</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-07.mp3</link>
            <description>Sarah Harrison of H&amp;S Enterprise talks about the steps she took to launch a successful career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690198</comments>
            <pubDate>Wed, 01 Apr 2009 15:07:15 +0100</pubDate>
            <guid isPermaLink="false">2690198</guid>        </item>
        <item>
            <title>WOTY:  Lynn O'Connor Vos of Grey Healthcare Group</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-06.mp3</link>
            <description>Lynn O'Connor Vos of Grey Healthcare Group discusses her career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690199</comments>
            <pubDate>Wed, 01 Apr 2009 15:04:55 +0100</pubDate>
            <guid isPermaLink="false">2690199</guid>        </item>
        <item>
            <title>WOTY:  Meryl Zausner of Novartis</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-05.mp3</link>
            <description>Meryl Zausner of Novartis Oncology reflects on her career. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690200</comments>
            <pubDate>Wed, 01 Apr 2009 15:00:08 +0100</pubDate>
            <guid isPermaLink="false">2690200</guid>        </item>
        <item>
            <title>TFC:  Changing Relationship between Manufacturers and Managed Care</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/tfc-rs-04.mp3</link>
            <description>Pharmaceutical Executive Editor Pat Clinton discusses How the relationship between Pharmaceutical Manufacturers and Managed Care has Changed with Ken Trader, VP of Strategic Accounts for Managed Care for ABSG. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690201</comments>
            <pubDate>Sun, 15 Mar 2009 14:44:27 +0100</pubDate>
            <guid isPermaLink="false">2690201</guid>        </item>
        <item>
            <title>TFC:  Patient Adherence Programs</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/tfc-rs-03.mp3</link>
            <description>Pharmaceutical Executive Editor Pat Clinton discusses Patient Adherence Programs with Jan Nielsen, VP of Clinical Services for ICS. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690202</comments>
            <pubDate>Sat, 14 Mar 2009 14:38:28 +0100</pubDate>
            <guid isPermaLink="false">2690202</guid>        </item>
        <item>
            <title>WOTY:  Ahnal Purohit of Purohit Navigation</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-04.mp3</link>
            <description>Ahnal Purohit of Purohit Navigation reflects on her career move from professor to president and how she translated her analytical skills to better brands. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481802</comments>
            <pubDate>Fri, 13 Mar 2009 17:41:04 +0100</pubDate>
            <guid isPermaLink="false">2481802</guid>        </item>
        <item>
            <title>WOTY:  Catherine Sohn of GlaxoSmithKline</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-03.mp3</link>
            <description>GlaxoSmithKline’s Catherine Sohn talks about the strength her father gave her to pursue her dreams and why it makes her want to give back. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481803</comments>
            <pubDate>Fri, 13 Mar 2009 17:38:37 +0100</pubDate>
            <guid isPermaLink="false">2481803</guid>        </item>
        <item>
            <title>WOTY: Carolyn Glynn of Roche</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-02.mp3</link>
            <description>Carolyn Glynn of Roche talks about representing her company and the challenges faced when championing outside constituents inside the company to give them a voice. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481804</comments>
            <pubDate>Fri, 13 Mar 2009 17:36:04 +0100</pubDate>
            <guid isPermaLink="false">2481804</guid>        </item>
        <item>
            <title>WOTY: HBA’s CEO Laurie Cooke and HBA President Ceci Zak</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/woty-rs-01.mp3</link>
            <description>Woman of the Year Podcast: HBA’s CEO Laurie Cooke teams up with HBA President Ceci Zak to share how the Woman of the Year Award has changed the face of industry. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481805</comments>
            <pubDate>Fri, 13 Mar 2009 17:31:29 +0100</pubDate>
            <guid isPermaLink="false">2481805</guid>        </item>
        <item>
            <title>TFC:  The potential impact of REMS</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/tfc-rs-02.mp3</link>
            <description>Pharmaceutical Executive Editor Joanna Breitstein discusses the potential impact of REMS with Jay Jackson. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481806</comments>
            <pubDate>Fri, 13 Mar 2009 17:19:40 +0100</pubDate>
            <guid isPermaLink="false">2481806</guid>        </item>
        <item>
            <title>TFC:  Is REMS the end of the world as we know it?</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/tfc-rs-01.mp3</link>
            <description>Pharmaceutical Executive Editor Joanna Breitstein sits down with Peyton Howell, president of consulting services and health policy for AmerisourceBergen Specialty Group, to examine key operational and clinical considerations of successful REMS programs. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481807</comments>
            <pubDate>Wed, 25 Feb 2009 20:52:51 +0100</pubDate>
            <guid isPermaLink="false">2481807</guid>        </item>
        <item>
            <title>Bill Trombetta Industry Audit (Part 5)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit5-rss.mp3</link>
            <description>Biogen Idec: This was Biogen's year, says Professor Bill Trombetta. In this episode, Bill spotlights some of the company's achievements, including an all-star performance at simultaneously managing assets and margins, then explores some ways in which companies need to re-envision their roles to be successful in tomorrow's market. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481808</comments>
            <pubDate>Mon, 15 Dec 2008 15:03:18 +0100</pubDate>
            <guid isPermaLink="false">2481808</guid>        </item>
        <item>
            <title>Bill Trombetta Industry Audit (Part 4)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit4-rss.mp3</link>
            <description>Genentech: Another permanent resident on the Top Four list, Genentech turns in mind-bending numbers. The big question: can Genentech keep it up. Bill Trombetta looks at the original biotech's remarkable successes and its challenges. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481809</comments>
            <pubDate>Mon, 15 Dec 2008 15:01:23 +0100</pubDate>
            <guid isPermaLink="false">2481809</guid>        </item>
        <item>
            <title>Bill Trombetta Industry Audit (Part 3)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit3-rss.mp3</link>
            <description>Johnson &amp; Johnson: A perennial member of the Top Four, J&amp;J defies the conventional wisdom; it's a big company that still manages to grow, a sprawling, diversified company that still has focus. And along with just three other companies on our list, it created shareholder value in 2007. Bill Trombetta explains how. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481810</comments>
            <pubDate>Mon, 15 Dec 2008 14:59:27 +0100</pubDate>
            <guid isPermaLink="false">2481810</guid>        </item>
        <item>
            <title>Bill Trombetta Industry Audit (Part 2)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit2-rss.mp3</link>
            <description>Eli Lilly: With double-digit growth in sales, and a solid improvement in revenue per employee, Lilly placed fourth in the Company of the Year rundown. Bill Trombetta explains Lilly's position as a big/small pharma and maps out the challenges that lie ahead for Lilly. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481811</comments>
            <pubDate>Mon, 15 Dec 2008 14:57:14 +0100</pubDate>
            <guid isPermaLink="false">2481811</guid>        </item>
        <item>
            <title>Bill Trombetta Industry Audit (Part 1)</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/audit1-rss.mp3</link>
            <description>How to measure a pharma company If you want to want to truly understand how well a company is performing, you need to get past the basics of revenue, profit margin, and price earnings ratio. In this episode, Bill Trombetta explains which metrics really get at the heart of good pharma management. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481812</comments>
            <pubDate>Mon, 15 Dec 2008 14:52:59 +0100</pubDate>
            <guid isPermaLink="false">2481812</guid>        </item>
        <item>
            <title>Tariq Arshad, MD of Pfizer</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/arshad-rss.mp3</link>
            <description>Want to know how to market in today’s resource-constrained environment? Tariq Arshad, MD, senior manager of worldwide commercial development for Pfizer, said that starting his career in Pakistan taught him everything he needed to know. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481813</comments>
            <pubDate>Wed, 15 Oct 2008 15:51:59 +0100</pubDate>
            <guid isPermaLink="false">2481813</guid>        </item>
        <item>
            <title>Michael Burke of Ovation Pharmaceuticals</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/burke-rss.mp3</link>
            <description>Michael Burke, chief commercial officer for Ovation Pharmaceuticals, talks about the difference leadership makes in the specialty space. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481814</comments>
            <pubDate>Wed, 15 Oct 2008 15:50:13 +0100</pubDate>
            <guid isPermaLink="false">2481814</guid>        </item>
        <item>
            <title>Barry Greene of Alnylam</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/greene-rss.mp3</link>
            <description>Barry Greene, President and COO of the RNAi powerhouse Alnylam, traces his rise to the top through mentors and medicine. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481815</comments>
            <pubDate>Wed, 15 Oct 2008 15:48:14 +0100</pubDate>
            <guid isPermaLink="false">2481815</guid>        </item>
        <item>
            <title>Martin Jernigan of Novo</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/jernigan-rss.mp3</link>
            <description>Martin Jernigan, associate vice president of Novo Nordisk’s liraglutides launch, talks about how to merge science and commercialization on an organizational level. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481816</comments>
            <pubDate>Wed, 15 Oct 2008 15:46:40 +0100</pubDate>
            <guid isPermaLink="false">2481816</guid>        </item>
        <item>
            <title>Sean McLoughlin of GlaxoSmithKline</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/mcloughlin-rss.mp3</link>
            <description>Leadership is about making courageous and clear decisions, says Sean McLoughlin, product director of GlaxoSmithKline’s diabetes franchise, which can be different for pharma’s growing number of customers. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481817</comments>
            <pubDate>Wed, 15 Oct 2008 15:45:06 +0100</pubDate>
            <guid isPermaLink="false">2481817</guid>        </item>
        <item>
            <title>Adnan Mjalli of TransTech Pharma</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/mjalli-rss.mp3</link>
            <description>Innovation hasn’t survived in Big Pharma, says Adnan Mjalli, founder, president, and CEO of TransTech Pharma. But bringing science back into the C-suite could help. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481818</comments>
            <pubDate>Wed, 15 Oct 2008 15:42:53 +0100</pubDate>
            <guid isPermaLink="false">2481818</guid>        </item>
        <item>
            <title>Angela Moskow of Sanofi-Aventis</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/moskow-rss.mp3</link>
            <description>Angela Moskow, vice president of diabetes marketing for Sanofi-Aventis, reflects on her career-long focus on diabetes, and offers some leadership tips she’s picked up along the way. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481819</comments>
            <pubDate>Wed, 15 Oct 2008 15:40:58 +0100</pubDate>
            <guid isPermaLink="false">2481819</guid>        </item>
        <item>
            <title>Wendy Niebler, DO of Shire Pharmaceuticals</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/niebler-rss.mp3</link>
            <description>How does a physician come to join the pharma industry? There’s no roadmap, says Wendy Niebler, DO, vice president of global medical affairs of ADHD for Shire Pharmaceuticals, but you can still make an impact on patients. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481820</comments>
            <pubDate>Wed, 15 Oct 2008 15:39:16 +0100</pubDate>
            <guid isPermaLink="false">2481820</guid>        </item>
        <item>
            <title>Rich Tillyer of Merck</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/tillyer-rss.mp3</link>
            <description>If companies are going to create best-in-class drugs, that work needs to start early in development, says Rich Tillyer, senior vice president, worldwide preclinical development for Merck. In this podcast, Tillyer traces his career at Merck and talks about the importance of providing scientists with the space to innovate. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481821</comments>
            <pubDate>Wed, 15 Oct 2008 15:36:56 +0100</pubDate>
            <guid isPermaLink="false">2481821</guid>        </item>
        <item>
            <title>Hoji Alimi of Oclulus</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/alimi-rss.mp3</link>
            <description>Life didn’t start easy for Hoji Alimi, Founder, President, and CEO of Oculus Innovative Sciences, who was exhiled from Iran as a teenager. But conviction in a compound which some have even called miracle water pointed the path toward success. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481822</comments>
            <pubDate>Wed, 15 Oct 2008 15:34:29 +0100</pubDate>
            <guid isPermaLink="false">2481822</guid>        </item>
        <item>
            <title>Cameron Durrant of Johnson &amp; Johnson</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/durrant-rss.mp3</link>
            <description>Cameron Durrant, Johnson &amp; Johnson’s worldwide vice president, virology global strategic marketing, tears up tradition and tells how visionary thinking can bring new leadership and instill more value in pharma. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481823</comments>
            <pubDate>Wed, 15 Oct 2008 15:30:55 +0100</pubDate>
            <guid isPermaLink="false">2481823</guid>        </item>
        <item>
            <title>Blair Gibson of Merck</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/gibson-rss.mp3</link>
            <description>Merck’s executive director of portfolio strategy and strategic planning, Blair Gibson, takes a deep dive into resource allocation and the new way to view pharma’s business. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481824</comments>
            <pubDate>Wed, 15 Oct 2008 15:28:51 +0100</pubDate>
            <guid isPermaLink="false">2481824</guid>        </item>
        <item>
            <title>Erik Harris of Elan</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/harris-rss.mp3</link>
            <description>Erik Harris, senior director of sales and marketing of Tysabri for Elan, talks about the challenges in marketing the drug and the leadership philosophy that paves the way. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481825</comments>
            <pubDate>Wed, 15 Oct 2008 15:28:45 +0100</pubDate>
            <guid isPermaLink="false">2481825</guid>        </item>
        <item>
            <title>Nancy Phelan of Wyeth</title>
            <link>http://pharmexec.scpodcasts.com/podcasts/phelan-rss.mp3</link>
            <description>Nancy Phelan, executive director of consumer communications and e-marketing for Wyeth, talks about perfecting DTC advertising in an imperfect world. (Source: Pharm Exec Podcast Interviews)</description>
            <author>Pharm Exec Podcast Interviews</author>
            <type>podcasts</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481826</comments>
            <pubDate>Wed, 15 Oct 2008 15:28:31 +0100</pubDate>
            <guid isPermaLink="false">2481826</guid>        </item>
    </channel>
</rss>

